103 results about "Salvia Officinalis Extract" patented technology

The invention discloses a scurf-removal and anti-hair loss shampoo. The shampoo finally obtained comprises, by mass percentage in 100% of the shampoo, 0.3-1% of rosemary extracts, 0.3-1% of thyme extracts, 0.3-1% of lavender extracts, 0.2-0.5% of nettle extracts, 0.2-0.5% of salvia officinalis extracts, 0.2-0.5% of chamomile extracts, 0.1-0.3% of equiisetum arvense, 15-30% of alkyl polyglucoside, 0.5-2.0% of cluster bean hydroxypropyltrimethyl ammonium chloride, 0.15-0.3% of essential oil, 0.15%-0.3% of preservatives and 0.03-0.06% of citric acid. The scurf-removal and anti-hair loss shampoo taking pure natural vegetable components as ingredients has functions of hair oil reduction, scurf removal and preventing hair loss, using effect of shampoo in chemical formulation is improved, and side effect of the shampoo is eliminated.

The invention discloses a refreshing moisturizing composition for a skin care product. The refreshing moisturizing composition comprises, by percent accounting for total mass of the skin care product, 1.0-4.0% of bambusa vulgaris leaf / stem extract, 0.24-0.8% of selaginella tamariscina extract, 0.24-0.8% of salvia officinalis extract, 0.02-0.5% of tara gum, 0.1-1.0% of ceramide and 0.5-3.0% of microcapsule wrappage. The refreshing moisturizing composition has three hydration effects including deep hydration, middle hydration and surface hydration, is good in moisturizing effect, long in lasting time and convenient to use and can be added into essence, water agents, facial masks, emulsions, cream, BB cream and sunscreen products. The invention further provides the skin care product applied in the refreshing moisturizing composition and a preparation method of the skin care product. The skin care product comprises, by mass, 2.1-10.1% of the refreshing moisturizing composition, 10.1-30.1% of oil-phase component, 0.06-0.12% of sodium hydroxide, 0.15-1.0% of auxiliary component and the balance of water-phase component.

The invention discloses a composition for treating seborrheic alopecie and a preparation method thereof. The composition is prepared from the following raw materials in parts by weight: 0.1 to 5 parts of cortex moutan extracts, 0.1 to 5 parts of cacumen platyclade extracts, 0.1 to 5 parts of rosemary extracts, 0.1 to 5 parts of tea plant extracts, 0.1 to 5 parts of radix angelicae sinensis extracts, 0.1 to 5 parts of radix astragali seu hedysari extracts, 0.1 to 5 parts of herba ecliptae extracts, 0.01 to 2 parts of salvia extracts, 0.01 to 2 parts of saw palmetto extracts, 0.01 to 2 parts of lupulus extracts, 0.01 to 2 parts of morinda citrifolia extracts, 0.01 to 0.05 part of biotin, 0.1 to 2 parts of phaseomannite, 0.1 to 1 part of hydrolyzed wheat protein, 0.1 to 1 part of oat glucan, 0.1 to 5 parts of zinc gluconate, 0.1 to 5 parts of herba menthae, 0.01 to 1 part of biphenyl acetate and 0.001 to 10 parts of fullerene and corresponding derivatives. The composition has the effect of preventing or treating seborrheic alopecie and androgen-dependent alopecia hereditarian.

The invention belongs to the field of natural medicines of traditional Chinese medicines, and particularly relates to a preparation method of salvia extract. The preparation method of salvia extract includes steps of damaging the salvia itself through ball-milling during the salvia extracting process; extracting the salvia by means of supercritical carbon dioxide; during the extracting process, adding carnosol and making it fully contact with extract; combining phenolic group of carnosol with danshinolic acid B hydroxyl under the high pressure state, and protecting the danshinolic acid B; thencarrying out the further extraction by enzyme and ultrasound wave so as to obtain sufficient salvia extract; reducing the salvia extract by lithium aluminium hydride to replace danshinolic acid B; removing danshinolic acid B and effectively protecting the danshinolic acid B. The preparation process is gentle in condition, high in extracting efficiency, and small in extractive damage.

The present invention discloses a medication and a preparation method and application thereof Active components of the medication are ginseng extract and salvia miltiorrhiza extract; a weight ratio between the ginseng extract and the salvia miltiorrhiza extract is 1:(0.1-20); a weight percentage content of total ginsenoside in the ginseng extract is larger than 50%; and a weight percentage contentof salvianolic acid in the salvia miltiorrhiza extract is larger than 50%. As shown in the result of Wistar rat myocardial infarction experiment and myocardial ischemia experiment, the reconstitutionof total ginsenoside and salvianolic acid has an optimal therapeutic effect, can effectively control Wistar rat myocardial infarction area and improve myocardial ischemia situation, furthermore, hasa same therapeutic effect with an original medicinal material reconstitution prescription. Pharmaceutical ingredient of the medication of the invention is clear and the quality of the medication can be controlled easily.

The invention belongs to the field of preparations, and particularly relates to radix salviae miltiorrhizae extract nanocrystalline self-stabilization Pickering emulsion and preparation method thereof. According to the radix salviae miltiorrhizae extract nanocrystalline self-stabilization Pickering emulsion disclosed by the invention, a radix salviae miltiorrhizae extract of which the salvianolicacid B content is 60-100mg / g, the tanshinol content is 3-10mg / g, the rosmarinic acid content is 3-10mg / g, the tanshinone II A content is 5-20mg / g, the cryptotanshinone content is 2-10mg / g and the tanshinone I content is 3-10mg / g is used as a raw material medicine, and the radix salviae miltiorrhizae extract, an oil phase and an aqueous phase are prepared into oil-in-water Pickering emulsion. The nanocrystalline self-stabilization Pickering emulsion having stability properties is prepared through using the radix salviae miltiorrhizae extract containing water-soluble medicine effect ingredientsand insoluble medicine effect ingredients of radix salviae miltiorrhizae at the same time as the raw material medicine, wherein the water-soluble ingredients of salvianolic acid B and the like are distributed in the aqueous phase, and insoluble ingredients of tanshinone and the like are partially distributed in the oil phase and are partially adsorbed on an emulsion droplet interface, so that theemulsion is stabilized.